The results suggest that the expression of TOX does not appear to be enormously increased in CAC (mucosa or tumor) compared to sCRC, in contrast to recent interesting observations of increased numbers of exhausted CD8+ T-cells in the context of IBD [11,13]. This evidence concerns the gene CD8A and inflammatory bowel disease.